glatiramer acetate

Also found in: Wikipedia.

glatiramer acetate


Pharmacologic class: Immunomodulator

Therapeutic class: Multiple sclerosis agent

Pregnancy risk category B


Unknown. Thought to alter immune processes believed to be responsible for pathogenesis of multiple sclerosis.


Injection: 20 mg lyophilized glatiramer acetate and 40 mg mannitol in single-use 2-ml vial (1-ml vial of sterile water for injection included for reconstitution)

Indications and dosages

To reduce frequency of relapses in relapsing-remitting multiple sclerosis

Adults: 20 mg/day subcutaneously


• Hypersensitivity to drug


Use cautiously in:

• pregnant or breastfeeding patients

• children (safety and efficacy not established).


• Give only by subcutaneous injection into arms, abdomen, hips, or thighs.

• Administer immediately after preparing. Discard unused portion.

Adverse reactions

CNS: abnormal dreams, agitation, anxiety, confusion, emotional lability, migraine, nervousness, speech disorder, stupor, tremor, weakness, vertigo

CV: chest pain, hypertension, palpitations, tachycardia, peripheral edema

EENT: eye disorder, nystagmus, ear pain, rhinitis

GI: nausea, vomiting, diarrhea, anorexia, gastroenteritis, other GI disorder, oral candidiasis, salivary gland enlargement, ulcerative stomatitis

GU: urinary urgency, hematuria, erectile dysfunction, amenorrhea, dysmenorrhea, menorrhagia, abnormal Papanicolaou smear, vaginal candidiasis, vaginal hemorrhage

Hematologic: ecchymosis, lymphadenopathy

Musculoskeletal: joint, back, or neck pain; foot drop; hypertonia

Respiratory: bronchitis, dyspnea, hyperventilation

Skin: eczema, erythema, diaphoresis, pruritus, rash, skin atrophy, skin nodules, urticaria, warts

Other: dental caries, facial edema, weight gain, herpes simplex, herpes zoster, cysts, chills, flulike symptoms, pain at injection site


None reported

Patient monitoring

Assess for immediate postinjection reaction, including flushing, chest pain, anxiety, breathing problems, and hives.

• Watch for transient chest pain, but be aware that this problem doesn't seem to be clinically significant.

• Check for vaginal bleeding.

• Watch for signs and symptoms of infection.

Patient teaching

• Teach patient how to prepare and self-administer drug. Supervise him the first time he does so.

Teach patient to recognize and immediately report signs and symptoms of postinjection reaction. Tell him this reaction may occur right away or up to several months after first dose.

• Caution patient to avoid driving and other hazardous activities until he knows how drug affects concentration and alertness.

Instruct patient to report signs or symptoms of infection or vaginal hemorrhage.

• Provide dietary counseling. Refer patient to dietitian if adverse GI effects significantly affect food intake.

• As appropriate, review all other significant and life-threatening adverse reactions.

McGraw-Hill Nurse's Drug Handbook, 7th Ed. Copyright © 2013 by The McGraw-Hill Companies, Inc. All rights reserved
References in periodicals archive ?
Compared with nonoverweight patients, obese patients had statistically significantly more relapses on first-line treatment with interferon beta and glatiramer acetate (annualized relapse rate, 1.29 versus 0.72) and a higher rate of second-line treatment (56.8 versus 38.7 percent).
Gilenya (fingolimod) at 0.5mg and 0.25mg was tested against once-daily subcutaneous injections of glatiramer acetate 20mg in decreasing disease activity over 12 months in patients with relapsing remitting multiple sclerosis.
announced that the two companies will team on the development and commercialization of GA Depot, a long-acting glatiramer acetate product.
Glatiramer Acetate. Glatiramer acetate is contraindicated during pregnancy in Europe due to insufficient information on its risk: benefit profile (can be used with caution in the USA) [20].
The generic form of glatiramer acetate injection, like all FDA-approved generics, is as safe and effective as the original medication.
[1] Other drugs precipitating Nicolau syndrome include penicillins, non-steroidal anti-inflammatory drugs like piroxicam and diclofenac, local anesthetics like lidocaine, antipsychotics, antiepileptics and glatiramer acetate. [2,3,4]
BANKING AND CREDIT NEWS-May 28, 2014-Mapi Pharma receives extension for Glatiramer Acetate Depot
Keywords: alemtuzumab, daclizumab, dimethyl fumarate, disease modifying treatment, fingolimod, glatiramer acetate, interferon beta, laquinimod, MCDONALD Criteria, multiple sclerosis, natalizumab, teriflunomide
* Prescribing interferon-beta or glatiramer acetate (Copaxone) for patients with progressive, nonrelapsing forms of multiple sclerosis (MS): These costly drugs often have troublesome side effects, and do not prevent the development of permanent disability in progressive MS.
On quality of life measures, monotherapy and combination therapy proved largely equal--and equally well tolerated--in the "CombiRx" study, in which half of the patients got the combination and a quarter got either glatiramer acetate (Copaxone) or interferon beta-la (Avonex) alone plus a placebo.
SAN DIEGO -- Glatiramer acetate and interferon beta-la used in combination were no more effective for patients with relapsing-remitting multiple sclerosis than were either agent alone in a 3-year, randomized trial.